Form Type: 4

SEC EDGAR Link
Accession Number:0001628280-23-018557
Date:2023-05-15
Issuer: AVALO THERAPEUTICS, INC. (AVTX)
Original Submission Date:

Reporting Person:

SULLIVAN CHRISTOPHER RYAN
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400 ROCKVILLE, MD 20850

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.75 2023-05-15 deemed execution date A 40,000 (a) 2024-05-15 2033-05-15 common stock 40,000 $2.75 40,000 direct
Footnotes
IDfootnote
f1 the stock option will vest in full on may 15, 2024, subject to the reporting person's continued service on such vesting date.
WhaleWisdom Logo

Elevate your investments